Recanalization for Symptomatic Non-acute Intracranial Large Vessel Occlusion: An Observational Study.

IF 3 2区 医学 Q2 PERIPHERAL VASCULAR DISEASE
Weili Li, Jun Zhang, Litang Han, Hongmei Niu, Wei Zhao, Yao Meng, Hao Yin, Lili Sun, Meimei Zheng, Wei Wang, Xiao He, Xiao Zhang, Yun Song, Ju Han
{"title":"Recanalization for Symptomatic Non-acute Intracranial Large Vessel Occlusion: An Observational Study.","authors":"Weili Li, Jun Zhang, Litang Han, Hongmei Niu, Wei Zhao, Yao Meng, Hao Yin, Lili Sun, Meimei Zheng, Wei Wang, Xiao He, Xiao Zhang, Yun Song, Ju Han","doi":"10.5551/jat.65539","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>This study investigated the efficacy and safety of endovascular revascularization for symptomatic non-acute atherosclerotic intracranial LVO.</p><p><strong>Methods: </strong>For non-acute atherosclerotic intracranial large vessel occlusion (LVO), despite aggressive medical treatment, recurrent ischemic stroke or transient ischemic attack related to the occluded artery still occurs repeatedly. This retrospective cohort study included stroke patients with intracranial LVO who received endovascular treatment (EVT), categorized by successful recanalization and the time interval from symptom onset to revascularization (<30 days vs. ≥ 30 days). The primary efficacy outcome was stroke recurrence or mortality at the 6-month follow-up.</p><p><strong>Results: </strong>Of the 264 patients in the study, 229 (87%) had successful recanalization, while 35 (13%) did not. In addition, 139 patients had recanalization times ≤ 30 days, and 125 had recanalization times >30 days. The successful recanalization group had a significantly lower rate of stroke recurrence or death during follow-up than the unsuccessful group (9.6% vs. 31.4%, adjusted odds ratio [OR]: 4.98, 95% confidence interval [CI]: 1.86 -13.37; P = 0.001). The group with a recanalization time ≤ 30 days also demonstrated a significantly lower rate of stroke recurrence or death during follow-up than the group with a recanalization time >30 days (7.9% vs.17.6%, P = 0.015). In addition, the rate of a favorable prognosis (modified Rankin Scale [mRS] 0-2) during the follow-up period was significantly higher in the successful recanalization group than in the successful recanalization group (71.1% vs. 51.4%, P = 0.021).</p><p><strong>Conclusion: </strong>These findings suggest that successful recanalization may have therapeutic potential for patients with non-acute intracranial large-vessel occlusion, particularly for those with LVO recanalization lasting <30 days, who show more significant benefits than those with longer-lasting recanalization [please check this carefully].</p>","PeriodicalId":15128,"journal":{"name":"Journal of atherosclerosis and thrombosis","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of atherosclerosis and thrombosis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5551/jat.65539","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: This study investigated the efficacy and safety of endovascular revascularization for symptomatic non-acute atherosclerotic intracranial LVO.

Methods: For non-acute atherosclerotic intracranial large vessel occlusion (LVO), despite aggressive medical treatment, recurrent ischemic stroke or transient ischemic attack related to the occluded artery still occurs repeatedly. This retrospective cohort study included stroke patients with intracranial LVO who received endovascular treatment (EVT), categorized by successful recanalization and the time interval from symptom onset to revascularization (<30 days vs. ≥ 30 days). The primary efficacy outcome was stroke recurrence or mortality at the 6-month follow-up.

Results: Of the 264 patients in the study, 229 (87%) had successful recanalization, while 35 (13%) did not. In addition, 139 patients had recanalization times ≤ 30 days, and 125 had recanalization times >30 days. The successful recanalization group had a significantly lower rate of stroke recurrence or death during follow-up than the unsuccessful group (9.6% vs. 31.4%, adjusted odds ratio [OR]: 4.98, 95% confidence interval [CI]: 1.86 -13.37; P = 0.001). The group with a recanalization time ≤ 30 days also demonstrated a significantly lower rate of stroke recurrence or death during follow-up than the group with a recanalization time >30 days (7.9% vs.17.6%, P = 0.015). In addition, the rate of a favorable prognosis (modified Rankin Scale [mRS] 0-2) during the follow-up period was significantly higher in the successful recanalization group than in the successful recanalization group (71.1% vs. 51.4%, P = 0.021).

Conclusion: These findings suggest that successful recanalization may have therapeutic potential for patients with non-acute intracranial large-vessel occlusion, particularly for those with LVO recanalization lasting <30 days, who show more significant benefits than those with longer-lasting recanalization [please check this carefully].

症状性非急性颅内大血管闭塞的再通术:一项观察性研究。
目的:探讨血管内血管重建术治疗有症状的非急性动脉粥样硬化性颅内LVO的疗效和安全性。方法:对于非急性动脉粥样硬化性颅内大血管闭塞(LVO),尽管积极治疗,与闭塞动脉相关的复发性缺血性卒中或短暂性缺血性发作仍反复发生。这项回顾性队列研究纳入了接受血管内治疗(EVT)的颅内LVO脑卒中患者,根据再通成功和从症状发作到血运重建的时间间隔(<30天vs.≥30天)进行分类。在6个月的随访中,主要疗效指标是卒中复发率或死亡率。结果:264例患者中,229例(87%)成功再通,35例(13%)失败。再通次数≤30天的有139例,再通次数≤30天的有125例。再通成功组随访期间卒中复发率或死亡率显著低于未通成功组(9.6% vs. 31.4%),调整优势比[or]: 4.98, 95%可信区间[CI]: 1.86 -13.37;P = 0.001)。再通时间≤30天组随访期间卒中复发率和死亡率明显低于再通时间≤30天组(7.9% vs.17.6%, P = 0.015)。此外,再通成功组随访期间预后良好率(改良Rankin量表[mRS] 0-2)明显高于再通成功组(71.1% vs. 51.4%, P = 0.021)。结论:这些研究结果提示,成功的再通对于非急性颅内大血管闭塞患者可能具有治疗潜力,特别是对于LVO再通持续时间<30天的患者,他们比持续时间更长的患者表现出更显著的益处[请仔细检查]。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.60
自引率
15.90%
发文量
271
审稿时长
1 months
期刊介绍: JAT publishes articles focused on all aspects of research on atherosclerosis, vascular biology, thrombosis, lipid and metabolism.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信